CN Patent

CN105229144A — 通过组合的遗传工程和化学工程经由正向编程产生肝细胞

Assigned to Fujifilm Cellular Dynamics Inc · Expires 2016-01-06 · 10y expired

What this patent protects

本发明提供了用于由多种细胞来源特别是多潜能干细胞产生肝细胞的方法，所述方法包括遗传手段和化学手段两者。

USPTO Abstract

本发明提供了用于由多种细胞来源特别是多潜能干细胞产生肝细胞的方法，所述方法包括遗传手段和化学手段两者。

Drugs covered by this patent

selumetinib-sulfate (SELUMETINIB SULFATE)

Patent Metadata

Patent number: CN105229144A
Jurisdiction: CN
Classification: —
Expires: 2016-01-06
Drug substance claim: No
Drug product claim: No
Assignee: Fujifilm Cellular Dynamics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.